Publications
(2013) In silico driven redesign of a clinically relevant antibody for the treatment of GD2 positive tumors. PLoS One. 8, e63359
NECAT
9700 S. Cass Ave.
Bldg. 436E
Lemont, IL 60439
630.252.0689
csalbego@cornell.edu
Copyright © 2025, NECAT
Design by FreeBiezz
